In Vivo Imaging and Kinetic Modeling of Novel Glycogen Synthase Kinase-3 Radiotracers [
glycogen synthase kinase 3
non-human primates
positron emission tomography
radiopharmaceutical
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
28 Jan 2023
28 Jan 2023
Historique:
received:
07
12
2022
revised:
21
01
2023
accepted:
24
01
2023
medline:
1
6
2023
pubmed:
1
6
2023
entrez:
1
6
2023
Statut:
epublish
Résumé
Glycogen synthase kinase 3 (GSK-3) is a potential therapeutic target for a range of neurodegenerative and psychiatric disorders. The goal of this work was to evaluate two leading GSK-3 positron emission tomography (PET) radioligands, [
Identifiants
pubmed: 37259346
pii: ph16020194
doi: 10.3390/ph16020194
pmc: PMC9959234
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIDA NIH HHS
ID : P30 DA046345
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG052414
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG054473
Pays : United States
Références
Int J Alzheimers Dis. 2011;2011:189246
pubmed: 21629738
ACS Pharmacol Transl Sci. 2021 Jul 20;4(4):1287-1294
pubmed: 34423266
Front Mol Neurosci. 2022 Jan 21;14:792364
pubmed: 35126052
Mol Pharm. 2021 Mar 1;18(3):1277-1284
pubmed: 33492962
Bioorg Med Chem Lett. 2005 Dec 1;15(23):5270-3
pubmed: 16202587
Neural Plast. 2019 May 2;2019:4209475
pubmed: 31191636
Neurochem Res. 2009 Feb;34(2):274-85
pubmed: 18584322
Cells. 2021 Jan 29;10(2):
pubmed: 33572709
Nucl Med Biol. 2010 Feb;37(2):205-14
pubmed: 20152720
J Med Chem. 2019 Nov 14;62(21):9600-9617
pubmed: 31535859
Nucl Med Biol. 2000 Aug;27(6):627-30
pubmed: 11056380
Theranostics. 2016 Feb 17;6(4):571-93
pubmed: 26941849
CNS Drugs. 2015 Jan;29(1):1-15
pubmed: 25380674
ACS Med Chem Lett. 2017 Feb 02;8(3):287-292
pubmed: 28337318
Pharmacol Ther. 2015 Apr;148:114-31
pubmed: 25435019
ACS Med Chem Lett. 2015 Mar 10;6(5):548-52
pubmed: 26005531
Expert Opin Ther Targets. 2018 Oct;22(10):833-848
pubmed: 30244615
J Neurochem. 2008 Mar;104(6):1433-9
pubmed: 18088381
Am J Nucl Med Mol Imaging. 2022 Feb 15;12(1):1-14
pubmed: 35295885
J Cereb Blood Flow Metab. 2014 Jul;34(7):1162-8
pubmed: 24736889
J Med Chem. 2022 Jan 27;65(2):1342-1351
pubmed: 34464131
ACS Chem Neurosci. 2017 Aug 16;8(8):1697-1703
pubmed: 28485573
Angew Chem Int Ed Engl. 2016 Aug 8;55(33):9601-5
pubmed: 27355874
Bioorg Med Chem Lett. 2019 Mar 15;29(6):778-781
pubmed: 30709652
J Fluor Chem. 2021 May;245:
pubmed: 33840834
Pharmacol Res. 2020 Jul;157:104819
pubmed: 32305493